Pruritus without rash

^[1]

Definition

Pruritus without rash (generalised pruritus sine materia) is itch lasting >6 weeks in the absence of primary skin lesions. The only skin findings are secondary changes from scratching: excoriations, prurigo nodularis and lichenification.^[2]

This presentation is a clinical sign of underlying systemic disease until proven otherwise, and mandates a comprehensive investigation.^[2]

Systemic Causes

The major systemic causes of generalised pruritus (mnemonic: SCALPED):^[2]

Aquagenic pruritus (itch triggered by water contact — shower/bath) is highly suggestive of polycythaemia vera; check FBC and JAK2.^[1]

Diagnostic Work-Up

^{[1] [10] [11] [12] [18] [19] [7]}

Every patient with chronic generalised pruritus without rash should have:^[2]

Escalate to CT/PET-CT if: abnormal bloods, weight loss, night sweats, lymphadenopathy, or initial work-up inconclusive but clinical suspicion remains high.^[2]

Measuring itch — the scales you must know

Accurate grading of chronic pruritus is essential for monitoring response to therapy and for documenting severity in clinic letters and trial protocols. Four validated instruments feature in fellowship-level practice. ^[1]

Visual Analogue Scale (VAS) for itch — single 100 mm line marked 0 (no itch) to 10 cm (worst imaginable itch). Score ≥4 = moderate itch; ≥7 = severe itch. Quickest tool at the bedside (takes 30 seconds). Limitation: captures intensity only — not quality, distribution or impact on sleep. ^[1]

Itch Severity Scale (ISS) — four domains scored 0-3 each: frequency (0=rare, 3=continuous), severity (0=mild, 3=severe), sleep impact (0=none, 3=loss of several nights' sleep), and effect on mood/leisure/social function (0=none, 3=severe). Total 0-12; ≥7 = severe itch. Useful in chronic pruritus trials because it captures quality-of-life impact rather than just intensity. ^[1]

5-D Itch Scale — five domains: Degree (intensity, 1-5), Duration (hours per day, 1-5), Direction (worsening/improving/stable, 1-5), Distribution (localised to generalised, 1-5), Disability (impact on sleep, work, leisure, 1-5). Total 5-25; ≥15 = severe. Has been validated specifically for pruritus associated with cholestasis, uraemia, atopic dermatitis and psoriasis — making it a strong single-page research instrument. ^[1]

UWMS (Unaffected-side Worst Morning Stiffness) style morning-itch diary / Itch Diary (one-week diary recording itch intensity, triggers, scratching frequency and sleep disruption) — useful before/after an intervention to capture change. ^[1]

In practice: at first clinic visit, document baseline VAS and ISS. Repeat at 4-6 weeks after any intervention (e.g., starting gabapentin or rifampicin). For cholestatic and uraemic pruritus, an improvement of ≥2 cm on VAS is considered clinically meaningful. ^[1]

Exclude scabies (burrows in finger webs, wrists, genitalia; household contacts) before diagnosing "pruritus without rash" — scabies is the commonest missed cause of generalised pruritus.^[3]

Management — General Measures

^{[1] [2] [11] [17] [14] [7] [2] [10] [11] [12] [17] [18] [19] [1]}

Pharmacology of pruritus treatment

^{[10] [18] [10] [11] [12] [20] [19] [7]}

All patients, regardless of cause:^[2]

• Emollients — generous and frequent (especially in xerosis/elderly).
• Cool bathing — avoid hot water (triggers itch).
• Loose cotton clothing — avoid wool and synthetics.
• Trim nails — reduce excoriation damage.
• Avoid heat and sweating.
• Antihistamines — have LIMITED efficacy in non-histaminergic itch (i.e., most causes of pruritus without rash). A sedating first-generation at night may help sleep even if it doesn't reduce itch.^[2]

Management — Cause-Specific

• Excoriations: linear scratch marks — confirm that the pruritus predates the excoriations (i.e., the excoriations are secondary).
• Prurigo nodularis: firm, dome-shaped, hyperkeratotic nodules (5-15 mm) on accessible areas (legs, arms) from chronic scratching/picking; very resistant to treatment.
• Lichenification: thickened, darkened, dry skin with exaggerated skin markings (like tree bark) from chronic rubbing — especially in atopic patients. ^[1]

These changes confirm the itch-scratch cycle but do NOT change the need to investigate the underlying systemic cause.^[2]

Regional and Specialised Subtypes of Pruritus

Generalised pruritus has classic regional variants in which itch is the only symptom — there is no primary rash, only secondary excoriations from scratching the localised area. Each has a stereotyped distribution that signals a specific underlying mechanism (usually neuropathic compression, not systemic disease). Recognising these saves the patient an unnecessary systemic work-up and points the clinician towards targeted therapy. ^[1]

^{[7] [6] [13]}

What is the key clinical clue in brachioradial pruritus?ShowHide

Which serum test should be done urgently in a pregnant woman with new-onset pruritus without rash?ShowHide

Detailed Subtype Profiles

Brachioradial pruritus is a localised neuropathic itch of the dorsolateral forearms, often seen in middle-aged white women, typically exacerbated by ultraviolet (UV) exposure and related to cervical spine pathology.^[7] In the Mayo Clinic series of 111 patients, 72% were female, mean age was 59 years (range 12-84 years), symptoms were bilateral in 75.7%, and 48.6% reported prolonged sun exposure. Of the 40.5% who underwent neck imaging, roughly a third showed cervical abnormalities (foraminal stenosis, intervertebral disc protrusion, spinal canal stenosis) — although no structural cause was found in most cases, and only a minority of those referred to neurology had their BRP attributed to a radiculopathy or peripheral neuropathy.^[6] Treatment follows the neuropathic-itch ladder: topical agents (menthol, capsaicin, lidocaine) for mild disease and systemic gabapentin, pregabalin or antidepressants for moderate-to-severe disease; no therapy is FDA-approved specifically for neuropathic itch, and outcomes in the Mayo series were mixed, with complete resolution uncommon.^[7][6]

Notalgia paraesthetica is an underdiagnosed chronic cutaneous neuropathy that presents with unilateral pruritus medial to the scapula on the mid-back, with or without an associated hyperpigmented or hypopigmented macule.^[13] It is prevalent in middle-aged women and is attributed to thoracic spine nerve compression; current theories propose a multifactorial mechanism including spinal entrapment and muscular compressive neuropathy.^[7] Management options are both pharmacological and non-pharmacological: topical capsaicin, lidocaine or menthol for milder symptoms, and systemic gabapentin, pregabalin or antidepressants for moderate-to-severe disease, in an individualised approach — this remains a difficult-to-treat condition.^[13][7]

Postherpetic neuralgia (PHN) is the most common complication of herpes zoster, and itch — postherpetic pruritus (PHP) — is its under-studied companion. In a single-centre cohort of PHN patients attending a pain clinic, 28% developed postherpetic pruritus; the mean onset was 96.5 days after vesicle formation and the mean duration was 278.6 days. Patients with PHN in the trigeminal nerve had a higher incidence of postherpetic pruritus than PHN at other sites, and patients with pruritus showed greater pain improvement at 3 and 4 months than those without.^[14] Postherpetic neuralgia is a classic neuropathic cause of chronic pruritus, and its itch is treated along standard neuropathic-itch lines — topical agents for mild disease, systemic gabapentin, pregabalin or antidepressants for moderate-to-severe disease.^[7]

Scalp pruritus is a frequent problem encountered in dermatological practice and a genuine diagnostic and therapeutic challenge. It may be localised to the scalp or extend to other body areas, and is sometimes associated not with a primary skin disease but only with lesions secondary to rubbing or scratching — the scalp equivalent of pruritus sine materia. Scalp pruritus is classified as dermatologic, neuropathic, systemic or psychogenic according to the underlying disease, and it can have a great impact on quality of life. A thorough evaluation — history, physical examination and further investigations where indicated — is essential: the therapeutic strategy comprises removal of aggravating factors and appropriate treatment of the underlying condition, with all treatments individualised to the patient.^[15]

Anogenital pruritus (pruritus ani, pruritus vulvae) is intense itching, acute or chronic, affecting the anal, perianal, perineal and genital skin — a dominant problem in the course of various cutaneous and systemic conditions.^[16] Anogenital skin is highly sensitive to soaps, perfumes, clothing and superficial trauma, and is more prone to itchy dermatoses because of warmth, friction, lack of aeration, sweating and occlusive inner garments. The associated disease spectrum is wide: localised infections, infestations, inflammatory dermatoses, allergic and irritant reactions, anorectal diseases, systemic causes, nutritional disorders and psychological causes — with idiopathic pruritus when no cause is found.^[16] Neuropathic anogenital pruritus affects 1-5% of adults and is often linked to lumbosacral spine issues once dermatologic conditions such as lichen sclerosus or lichen simplex chronicus have been ruled out.^[7] Patients are often reluctant to present early and usually attend later with depigmentation and lichenification secondary to constant scratching; many self-medicate with over-the-counter combination topical steroids, causing complications such as skin atrophy and striae. Work-up: proper clinical history and examination, with skin scraping for fungus and itch mite, skin biopsy, patch testing and relevant blood investigations to rule out systemic conditions where needed.^[16]

Intrahepatic cholestasis of pregnancy (ICP) is the pregnancy-specific pruritic disorder that mandates urgent recognition: it is the most common liver disorder specific to pregnancy, characterised by raised serum bile acids and aminotransferases, and typically presents with pruritus as its defining symptom — itch without any primary skin eruption. Ursodeoxycholic acid (UDCA) remains the first-line therapeutic option. Clinical management — including decisions about the timing of delivery — is guided principally by serum bile acid concentrations, with the aim of reducing perinatal complications; a firm diagnosis therefore rests on serum bile acids rather than on the presence or absence of a rash.^[8]

Drug-induced pruritus is defined as generalised itching without skin lesions caused by a drug — the archetypal "itch without rash". Itching associated with drug-induced cholestasis is among the common dermatologic adverse events that induce itch. Drugs known to induce itch without skin lesions include opioids, antimalarials and hydroxyethyl starch, whose clinical features and proposed mechanisms have been specifically investigated.^[9] Among targeted anticancer drugs, dAEs such as acneiform rashes, dry skin, hand-foot syndrome, paronychia and itching are frequent — itching is a common side effect of epidermal growth factor receptor inhibitors — and although not life-threatening these eruptions impair quality of life, force dose reduction and may compromise cancer therapy; effective supportive antipruritic treatment without interrupting the anticancer drug is therefore important.^[9] Management: the principle of treatment is discontinuation of the suspected causative drug, except for anticancer medications, where supportive antipruritic treatment should continue alongside the drug; where itch persists after withdrawal or the drug cannot be stopped, vigorous symptomatic antipruritic treatment and type-specific therapies are undertaken.^[9]

^{[14] [7] [6] [19] [8] [6] [7] [13] [14] [9]}

Special Populations

• Elderly: xerosis is the commonest cause; emollients are the mainstay. Also higher risk of cholestasis (PBC), CKD, malignancy and drug-induced pruritus. Check ferritin (iron deficiency without anaemia is easily missed).
• Pregnancy: intrahepatic cholestasis of pregnancy (ICP) — pruritus (especially palms/soles) without rash in the 3rd trimester; raised serum bile acids; risk of premature birth and stillbirth.
• Dialysis patients: uraemic pruritus affects ~40-80%; gabapentin post-dialysis and NB-UVB are first-line.^[2]

Exam Pearls

^[1]

Red Flags

Exam application bank (NEET-PG / INICET)

One-line answer

Pruritus without rash (generalised pruritus sine materia) is itch lasting >6 weeks without primary skin lesions — only secondary excoriations, prurigo nodularis or lichenification. It is a clinical sign of SYSTEMIC DISEASE until proven otherwise, requiring a comprehensive work-up (FBC, U&E, LFTs including ALP/GGT, TFTs, glucose/HbA1c, iron studies, hepatitis B/C, HIV, serum electrophoresis, urinalysis, CXR). The mnemonic SCALPED covers the major causes: Skin (xerosis), Chronic kidney disease, Anaemia/iron deficiency, Liver (cholestasis/PBC), Polycythaemia vera, Endocrine (thyroid/diabetes), Drugs. Hodgkin's lymphoma is the classic malignancy association. Management is cause-specific: cholestyramine/rifampicin/naltrexone for cholestatic itch, gabapentin/phototherapy for uraemic itch, gabapentin/capsaicin for neuropathic, treat malignancy for malignancy-associated. Antihistamines have LIMI

Worked stems (answer without another resource)

Stem 1 — Classic presentation. Map symptoms to mechanism; name the first investigation and first treatment step with dose/route if drug therapy is standard. ^[1]

Stem 2 — Unstable / complicated. List red flags that force immediate resuscitation, theatre, ICU, antidote, or reperfusion — and what you do in the first 15 minutes. ^[1]

Stem 3 — Atypical group. Elderly, pregnancy, child, or immunocompromised: how presentation and thresholds change. ^[1]

Stem 4 — Differential trap. Name the three closest mimics and one discriminator for each. ^[1]

Stem 5 — Disposition. Who goes home with safety-netting, who is admitted, who needs HDU/ICU/theatre, and what follow-up is mandatory. ^[1]

Rapid viva checklist

1. Definition + classification
2. Pathophysiology chain
3. Bedside signs / criteria
4. Score with exact components (if any)
5. Emergency bundle
6. Definitive therapy with doses
7. Complications of disease and of treatment
8. Special populations
9. Guideline/trial name if classic
10. Three exam traps

Coverage self-check

If you cannot answer any stem above from this page alone, re-read the matching section — the page is intended to be self-sufficient for final-prof and NEET-PG/INICET questions on Pruritus without rash.

^[1]

References20ShowHide

1. [1]Tefferi A, Barbui T. Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management Am J Hematol, 2023.PMID 37357958
2. [2]Butler DC, Berger T, Elmariah S, et al. Chronic Pruritus: A Review JAMA, 2024.PMID 38809527
3. [3]Sunderkötter C, Wohlrab J, Hamm H. Scabies: Epidemiology, Diagnosis, and Treatment Dtsch Arztebl Int, 2021.PMID 34615594
4. [4]Borda LJ, Perper M, Keri JE. Treatment of seborrheic dermatitis: a comprehensive review J Dermatolog Treat, 2019.PMID 29737895
5. [5]Geisler AN, Phillips GS, Barrios DM, et al. Immune checkpoint inhibitor-related dermatologic adverse events J Am Acad Dermatol, 2020.PMID 32454097
6. [6]Mirzoyev SA, Davis MD. Brachioradial pruritus: Mayo Clinic experience over the past decade Br J Dermatol, 2013.PMID 23796379
7. [7]Mashoudy KD, Brooks SG, Andrade LF, et al. From Compression to Itch: Exploring the Link Between Nerve Compression and Neuropathic Pruritus Am J Clin Dermatol, 2025.PMID 39417971
8. [8]Jurk S, Kremer A, Schleussner E. The Latest on Intrahepatic Cholestasis of Pregnancy - Update 2026 Geburtshilfe Frauenheilkd, 2026.PMID 42343909
9. [9]Ebata T. Drug-Induced Itch Management Curr Probl Dermatol, 2016.PMID 27578085
10. [10]Düll MM, Kremer AE. Management of Chronic Hepatic Itch Dermatol Clin, 2018.PMID 29929600
11. [11]Verduzco HA, Shirazian S. CKD-Associated Pruritus: New Insights Into Diagnosis, Pathogenesis, and Management Kidney Int Rep, 2020.PMID 32954065
12. [12]Ko MJ, Peng YS, Wu HY. Uremic pruritus: pathophysiology, clinical presentation, and treatments Kidney Res Clin Pract, 2023.PMID 35545226
13. [13]Howard M, Sahhar L, Andrews F, et al. Notalgia paresthetica: a review for dermatologists Int J Dermatol, 2018.PMID 29243804
14. [14]Park C, John H, Lee J, et al. The relative frequency of pruritus in postherpetic neuralgia patients presenting to the pain clinic and associative factors Medicine (Baltimore), 2022.PMID 36107606
15. [15]Rattanakaemakorn P, Suchonwanit P. Scalp Pruritus: Review of the Pathogenesis, Diagnosis, and Management Biomed Res Int, 2019.PMID 30766878
16. [16]Swamiappan M. Anogenital Pruritus - An Overview J Clin Diagn Res, 2016.PMID 27190932
17. [17]Mayo MJ, Carey E, Smith HT, et al. Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis Dig Dis Sci, 2023.PMID 35704252
18. [18]Trivella J, Levy C. Safety considerations for the management of cholestatic itch Expert Opin Drug Saf, 2021.PMID 33836644
19. [19]Steinman HK, Greaves MW. Aquagenic pruritus J Am Acad Dermatol, 1985.PMID 2411768
20. [20]Deeks ED. Difelikefalin: First Approval Drugs, 2021.PMID 34674115